KOONCE DRUG COMPANY, INC. — Form D
KOONCE DRUG COMPANY, INC. of TABOR CITY, NC, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-26. The offering totals $1.1M, of which $55K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2017-04-26
- Form: D
- Accession: 0001703897-17-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.1M
- Amount sold: $55K
- Remaining: $1.1M
- Investors: 1
- Date of first sale: 2016-06-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-285554
Issuer
- Name: KOONCE DRUG COMPANY, INC.
- CIK: 0001703897
- Entity type: Corporation
- Jurisdiction: NORTH CAROLINA
- Address: 220 S. MAIN STREET, TABOR CITY, NC, 28463
- Phone: 910-653-4800
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| CAROLINE GRADY KOONCE | Director | TABOR CITY, NC |
| STERLING GRADY KOONCE | Director | TABOR CITY, NC |
| CAROLINE GRADY KOONCE | Executive Officer | TABOR CITY, NC |
| STERLING GRADY KOONCE | Executive Officer | TABOR CITY, NC |
More